Enhanced cardiovascular diagnostics using wearable ECG and bioimpedance monitoring with LightGBM classifier

IF 10.61 Q3 Biochemistry, Genetics and Molecular Biology Biosensors and Bioelectronics: X Pub Date : 2025-03-26 DOI:10.1016/j.biosx.2025.100617
Prince Jain , Ramji Gupta , Anand Joshi , Andrey Kuzmin
{"title":"Enhanced cardiovascular diagnostics using wearable ECG and bioimpedance monitoring with LightGBM classifier","authors":"Prince Jain ,&nbsp;Ramji Gupta ,&nbsp;Anand Joshi ,&nbsp;Andrey Kuzmin","doi":"10.1016/j.biosx.2025.100617","DOIUrl":null,"url":null,"abstract":"<div><div>Cardiovascular diseases (CVDs) are the leading cause of death worldwide, necessitating advanced diagnostic and monitoring tools. Traditional methods of cardiac monitoring face challenges such as limited availability, high costs, and continuous physician oversight. Recent advancements in mobile health (mHealth) technologies, including wearable devices and mobile applications, offer promising solutions for continuous and real-time monitoring of vital signs such as ECG, bioimpedance, and physical activity. This study focuses on integrating these monitoring modalities to enhance the accuracy and reliability of cardiovascular diagnostics. Specifically, we explore the use of the MAX30001 device for precise ECG and bioimpedance measurements in wearable applications. Machine learning techniques, particularly LightGBM, are employed to classify cardiac conditions based on the collected data. The LightGBM classifier achieved a test set accuracy of 94.49 %, with precision, recall, and F1-scores above 0.95 for all classes. The model's performance was further validated through cross-validation (CV), yielding a 5-fold CV accuracy of 95.86 % and a 10-fold CV accuracy of 96.16 %. The ROC curve analysis showed excellent discriminatory ability with AUC values close to 1. These findings highlight the potential applications of advanced mHealth solutions in providing continuous, accurate, and real-time monitoring of cardiovascular health, which can lead to better patient management and outcomes through timely and informed interventions.</div></div>","PeriodicalId":260,"journal":{"name":"Biosensors and Bioelectronics: X","volume":"24 ","pages":"Article 100617"},"PeriodicalIF":10.6100,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biosensors and Bioelectronics: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590137025000445","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, necessitating advanced diagnostic and monitoring tools. Traditional methods of cardiac monitoring face challenges such as limited availability, high costs, and continuous physician oversight. Recent advancements in mobile health (mHealth) technologies, including wearable devices and mobile applications, offer promising solutions for continuous and real-time monitoring of vital signs such as ECG, bioimpedance, and physical activity. This study focuses on integrating these monitoring modalities to enhance the accuracy and reliability of cardiovascular diagnostics. Specifically, we explore the use of the MAX30001 device for precise ECG and bioimpedance measurements in wearable applications. Machine learning techniques, particularly LightGBM, are employed to classify cardiac conditions based on the collected data. The LightGBM classifier achieved a test set accuracy of 94.49 %, with precision, recall, and F1-scores above 0.95 for all classes. The model's performance was further validated through cross-validation (CV), yielding a 5-fold CV accuracy of 95.86 % and a 10-fold CV accuracy of 96.16 %. The ROC curve analysis showed excellent discriminatory ability with AUC values close to 1. These findings highlight the potential applications of advanced mHealth solutions in providing continuous, accurate, and real-time monitoring of cardiovascular health, which can lead to better patient management and outcomes through timely and informed interventions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
增强心血管诊断使用可穿戴心电图和生物阻抗监测与LightGBM分类器
心血管疾病(cvd)是世界范围内的主要死亡原因,需要先进的诊断和监测工具。传统的心脏监测方法面临着诸如有限的可用性、高成本和持续的医生监督等挑战。移动医疗(mHealth)技术的最新进展,包括可穿戴设备和移动应用程序,为持续实时监测心电图、生物阻抗和身体活动等生命体征提供了有前途的解决方案。本研究的重点是整合这些监测模式,以提高心血管诊断的准确性和可靠性。具体来说,我们探索了MAX30001设备在可穿戴应用中用于精确ECG和生物阻抗测量的使用。机器学习技术,特别是LightGBM,被用于根据收集的数据对心脏病进行分类。LightGBM分类器达到了94.49%的测试集准确率,所有类别的准确率、召回率和f1分数都在0.95以上。通过交叉验证(CV)进一步验证了模型的性能,得到5倍CV准确率为95.86%,10倍CV准确率为96.16%。ROC曲线分析显示,该方法鉴别能力较好,AUC值接近1。这些发现突出了先进的移动医疗解决方案在提供心血管健康的连续、准确和实时监测方面的潜在应用,这可以通过及时和知情的干预措施改善患者管理和结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Biosensors and Bioelectronics: X
Biosensors and Bioelectronics: X Biochemistry, Genetics and Molecular Biology-Biophysics
CiteScore
4.60
自引率
0.00%
发文量
166
审稿时长
54 days
期刊介绍: Biosensors and Bioelectronics: X, an open-access companion journal of Biosensors and Bioelectronics, boasts a 2020 Impact Factor of 10.61 (Journal Citation Reports, Clarivate Analytics 2021). Offering authors the opportunity to share their innovative work freely and globally, Biosensors and Bioelectronics: X aims to be a timely and permanent source of information. The journal publishes original research papers, review articles, communications, editorial highlights, perspectives, opinions, and commentaries at the intersection of technological advancements and high-impact applications. Manuscripts submitted to Biosensors and Bioelectronics: X are assessed based on originality and innovation in technology development or applications, aligning with the journal's goal to cater to a broad audience interested in this dynamic field.
期刊最新文献
Nanomembrane sensor-integrated central venous catheter for continuous monitoring of electrolytes in blood serum A review on the impact of AI-enabled thermal imaging and IoT sensor fusion on early detection of mastitis in dairy cattle Electrochemical sensing of hormonal serotonin levels in crayfish Near field communication integrated lateral flow assays Next-generation polarimetric biosensors: machine learning–driven GeSe photodetectors for noninvasive glucose monitoring
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1